 NEW JERSEY , Dec. 04, 2020 GLOBE NEWSWIRE -- Silo Pharma, Inc. OTCQB: SILO a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that it has been requested by the OTC Markets Group the OTC Markets to comment on recent promotional activity. 